Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
34925085
TITLE
Potential Genetic Overlap Between Insomnia and Sleep Symptoms in Major Depressive Disorder: A Polygenic Risk Score Analysis.
ABSTRACT
The prevalence of insomnia and hypersomnia in depressed individuals is substantially higher than that found in the general population. Unfortunately, these concurrent sleep problems can have profound effects on the disease course. Although the full biology of sleep remains to be elucidated, a recent genome-wide association (GWAS) of insomnia, and other sleep traits in over 1 million individuals was recently published and provides many promising hits for genetics of insomnia in a population-based sample. Using data from the largest available GWAS of insomnia and other sleep traits, we sought to test if sleep variable PRS scores derived from population-based studies predicted sleep variables in samples of depressed cases [Psychiatric Genomics Consortium - Major Depressive Disorder subjects (PGC MDD)]. A leave-one-out analysis was performed to determine the effects that each individual study had on our results. The only significant finding was for insomnia, where -value threshold, = 0.05 was associated with insomnia in our PGC MDD sample ( = 1.75 , = 0.006). Our results reveal that <1% of variance is explained by the variants that cover the two significant -value thresholds, which is in line with the fact that depression and insomnia are both polygenic disorders. To the best of our knowledge, this is the first study to investigate genetic overlap between the general population and a depression sample for insomnia, which has important treatment implications, such as leading to novel drug targets in future research efforts.
Copyright © 2021 Melhuish Beaupre, Tiwari, Gonçalves, Zai, Marshe, Lewis, Martin, McIntosh, Adams, Baune, Levinson, Boomsma, Penninx, Breen, Hamilton, Awasthi, Ripke, Jones, Jones, Byrne, Hickie, Potash, Shi, Weissman, Milaneschi, Shyn, Geus, Willemsen, Brown, Kennedy and Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium.
DATE PUBLISHED
2021
HISTORY
PUBSTATUS PUBSTATUSDATE
received 2021/07/22
accepted 2021/11/01
entrez 2021/12/20 06:05
pubmed 2021/12/21 06:00
medline 2021/12/21 06:01
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Melhuish Beaupre LM Melhuish Beaupre Lindsay M LM Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Tiwari AK Tiwari Arun K AK Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Gonçalves VF Gonçalves Vanessa F VF Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Zai CC Zai Clement C CC Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Marshe VS Marshe Victoria S VS Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Lewis CM Lewis Cathryn M CM Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
Martin NG Martin Nicholas G NG Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
McIntosh AM McIntosh Andrew M AM Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Adams MJ Adams Mark J MJ Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Baune BT Baune Bernhard T BT Melbourne Medical School, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Levinson DF Levinson Doug F DF Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.
Boomsma DI Boomsma Dorret I DI Department of Biological Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, Netherlands.
Penninx BWJH Penninx Brenda W J H BWJH Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, Netherlands.
Breen G Breen Gerome G National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre, King's College London, London, United Kingdom.
Hamilton S Hamilton Steve S The Permanente Medical Group, San Francisco, CA, United States.
Awasthi S Awasthi Swapnil S Department of Psychiatry and Psychotherapy, Universitäts Medizin Berlin Campus Charité Mitte, Berlin, Germany.
Ripke S Ripke Stephan S Department of Psychiatry, Charité, Berlin, Germany.
Jones L Jones Lisa L Psychological Medicine, University of Worcester, Worcester, United Kingdom.
Jones I Jones Ian I Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom.
Byrne EM Byrne Enda M EM Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia.
Hickie IB Hickie Ian B IB Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.
Potash JP Potash James P JP Psychiatry Department, University of Iowa, Iowa City, IA, United States.
Shi J Shi Jianxin J Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States.
Weissman MM Weissman Myrna M MM Division of Epidemiology, New York State Psychiatric Institute, New York, NY, United States.
Milaneschi Y Milaneschi Yuri Y Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, Netherlands.
Shyn SI Shyn Stanley I SI Washington Permanente Medical Group, Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
de Geus EJC de Geus Eco J C EJC Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, Netherlands.
Willemsen G Willemsen Gonneke G Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, Netherlands.
Brown GM Brown Gregory M GM Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Kennedy JL Kennedy James L JL Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
INVESTIGATORS
JOURNAL
VOLUME: 12
ISSUE:
TITLE: Frontiers in psychiatry
ISOABBREVIATION: Front Psychiatry
YEAR: 2021
MONTH:
DAY:
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Print
ISSN: 1664-0640
ISSNTYPE: Print
MEDLINE JOURNAL
MEDLINETA: Front Psychiatry
COUNTRY: Switzerland
ISSNLINKING: 1664-0640
NLMUNIQUEID: 101545006
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
COMMENTS AND CORRECTIONS
GRANTS
GENERAL NOTE
KEYWORDS
KEYWORD
hypersomnia
insomnia
major depressive disorder
polygenic risk
sleep
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's